Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$580,000 |
 |
MedtronicMDT |
-$110,000 |
 |
Intuitive SurgicalISRG |
$16,000 |
 |
MedpaceMEDP |
-$32,000 |
 |
Tandem Diabetes CareTNDM |
$16,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer | Nov 19, 2025 | Sell | $1K - $15K |
| Bruce Westerman | Apr 21, 2025 | Sell | $1K - $15K |
| Rob Bresnahan | Apr 8, 2025 | Buy | $1K - $15K |
| Jefferson Shreve | Apr 7, 2025 | Buy | $15K - $50K |
| Bruce Westerman | Mar 3, 2025 | Buy | $1K - $15K |
| Ro Khanna | Oct 14, 2024 | Buy | $1K - $15K |
| Ro Khanna | Sep 9, 2024 | Buy | $1K - $15K |
| Mike Kelly | Apr 11, 2024 | Sell | $1K - $15K |
| Rohit Khanna Democrat | Feb 13, 2024 | Buy | $1K - $15K |
FAQ - Congress Trading
Josh Gottheimer sold Edwards Lifesciences shares most recently on November 19, 2025.
Jefferson Shreve has bought the most EW stock in the last 2 years, with an estimated value of $33,000.
Mike Kelly has sold the most EW stock in the last 2 years, with an estimated value of $8,000.
According to our estimates, the net value of trades by US politicians for Edwards Lifesciences in the last 2 years is positive, amounting to $49,000. This indicates that US politicians have reasons to believe that the stock is going to go up.
Over the last 2 years, insider transactions for Edwards Lifesciences have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
